ArticleJournal of cellular and molecular medicine2022

FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway.

Xiaodan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.